{"id":"https://openalex.org/W1929987490","doi":null,"title":"Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.","display_name":"Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.","publication_year":2002,"publication_date":"2002-05-15","ids":{"openalex":"https://openalex.org/W1929987490","mag":"1929987490","pmid":"https://pubmed.ncbi.nlm.nih.gov/12019144"},"language":"en","primary_location":{"id":"pmid:12019144","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12019144","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108451743","display_name":"Shan Man","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Shan Man","raw_affiliation_strings":["Departments of Medical Biophysics, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5 Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medical Biophysics, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5 Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025020524","display_name":"Guido Bocci","orcid":"https://orcid.org/0000-0001-7120-9141","observed_orcids":["https://orcid.org/0000-0001-7120-9141"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guido Bocci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075999310","display_name":"Giulio Francia","orcid":"https://orcid.org/0000-0002-3752-3070","observed_orcids":["https://orcid.org/0000-0002-3752-3070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giulio Francia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050043876","display_name":"Shane K. Green","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shane K Green","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110029133","display_name":"Serge Jothy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Serge Jothy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007537368","display_name":"Douglas Hanahan","orcid":"https://orcid.org/0000-0002-0883-5251","observed_orcids":["https://orcid.org/0000-0002-0883-5251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas Hanahan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059035410","display_name":"Peter B\u00f6hlen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Bohlen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074599944","display_name":"Daniel J. Hicklin","orcid":"https://orcid.org/0009-0005-3474-9348","observed_orcids":["https://orcid.org/0009-0005-3474-9348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J Hicklin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020870956","display_name":"Gabriele Bergers","orcid":"https://orcid.org/0000-0003-3545-5171","observed_orcids":["https://orcid.org/0000-0003-3545-5171"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriele Bergers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5010799165","display_name":"Robert S. Kerbel","orcid":"https://orcid.org/0000-0002-6015-2570","observed_orcids":["https://orcid.org/0000-0002-6015-2570"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert S Kerbel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.2989,"has_fulltext":false,"cited_by_count":314,"citation_normalized_percentile":{"value":0.98221649,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"62","issue":"10","first_page":"2731","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.8690000176429749},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9879999756813049},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.7239999771118164},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.628000020980835},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7789999842643738},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9350000023841858},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/pancreatic-islet-cell-carcinoma","display_name":"pancreatic islet cell carcinoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/anti-egfr-monoclonal-antibody","display_name":"anti-EGFR monoclonal antibody","score":0.47200000286102295},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5180000066757202},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.6499999761581421},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7621318101882935},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.7380741834640503},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5560144186019897},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4855944514274597},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46300792694091797},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4340100586414337},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.41657668352127075},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3361203670501709},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3254851698875427}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004326","descriptor_name":"Drinking","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017978","descriptor_name":"Receptors, Growth Factor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019073","descriptor_name":"HT29 Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020794","descriptor_name":"Receptor Protein-Tyrosine Kinases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:12019144","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12019144","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:arpi.unipi.it:11568/71399","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11568/71399","pdf_url":null,"source":{"id":"https://openalex.org/S4377196265","display_name":"CINECA IRIS Institutial research information system (University of Pisa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I108290504","host_organization_name":"University of Pisa","host_organization_lineage":["https://openalex.org/I108290504"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:1929987490","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12019144","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8380699837","display_name":"Host Cell Assisted Primary and Metastatic Tumor Regrowth after Chemotherapy","funder_award_id":"R01CA041233","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W103592546","https://openalex.org/W142377240","https://openalex.org/W143705936","https://openalex.org/W1482290746","https://openalex.org/W1720858567","https://openalex.org/W1943173994","https://openalex.org/W2015809080","https://openalex.org/W2022662750","https://openalex.org/W2029883816","https://openalex.org/W2034269086","https://openalex.org/W2043410848","https://openalex.org/W2059294866","https://openalex.org/W2084468930","https://openalex.org/W2087525057","https://openalex.org/W2088257209","https://openalex.org/W2100227988","https://openalex.org/W2104316189","https://openalex.org/W2107139417","https://openalex.org/W2119308535","https://openalex.org/W2140868957","https://openalex.org/W2155056678","https://openalex.org/W2161714684"],"related_works":["https://openalex.org/W2114592067","https://openalex.org/W2946778052","https://openalex.org/W2328243021","https://openalex.org/W945092805","https://openalex.org/W2142912450","https://openalex.org/W1698000928","https://openalex.org/W2126092906","https://openalex.org/W2028665955","https://openalex.org/W2108018907","https://openalex.org/W2067992759"],"abstract_inverted_index":{"A":[0],"number":[1],"of":[2,12,43,66,76,99,185,216,234,283,295],"recent":[3],"preclinical":[4,127],"studies":[5],"have":[6],"sparked":[7],"interest":[8],"in":[9,29,86,159,207,224,242,252,298],"the":[10,31,90,108,211,290,293],"concept":[11],"exploiting":[13],"conventional":[14],"chemotherapeutic":[15,68],"drugs":[16,69],"as":[17],"antiangiogenics.":[18],"Such":[19,315],"antiangiogenic":[20,62,326],"activity":[21],"is":[22,33,70,112],"achieved":[23],"or":[24,154,161,182],"optimized":[25],"by":[26],"metronomic-dosing":[27],"protocols":[28],"which":[30,189,304],"drug":[32,91,203],"given":[34,114],"at":[35,96],"comparatively":[36],"low":[37,97],"doses":[38],"using":[39,210],"a":[40,87,104,137,299,316],"frequent":[41],"schedule":[42],"administration":[44],"(e.g.,":[45],"once":[46],"to":[47,94,116,135,173,192,201,275,312],"three":[48],"times":[49],"per":[50],"week)":[51],"with":[52,58,142,254,325],"no":[53],"breaks,":[54],"particularly":[55,71,320],"when":[56,125,205,250],"combined":[57],"an":[59,243,255],"endothelial":[60,257],"cell-specific":[61],"drug.":[63],"The":[64,232],"use":[65],"p.o.":[67,115,133,236,280,300],"suitable":[72],"for":[73,150,180,268,323],"this":[74],"type":[75],"treatment":[77,141,213,238],"strategy.":[78],"We":[79,131],"tested":[80,206],"one":[81],"such":[82],"drug,":[83],"cyclophosphamide":[84],"(CTX),":[85],"protocol":[88],"wherein":[89],"was":[92,229],"administered":[93],"mice":[95,228],"doses,":[98],"approximately":[100],"10-40":[101],"mg/kg":[102],"on":[103],"daily":[105,279],"basis":[106],"through":[107],"drinking":[109],"water.":[110],"CTX":[111,134,237,284,297],"typically":[113],"patients,":[117],"but":[118],"it":[119],"has":[120],"almost":[121,174],"always":[122],"been":[123],"injected":[124],"treating":[126],"mouse":[128,270],"tumor":[129,168],"models.":[130],"found":[132,200],"be":[136,171,202,319],"safe":[138],"and":[139,309],"convenient":[140],"significant":[143],"antitumor":[144],"efficacy.":[145],"Growth":[146],"delays":[147],"were":[148,198,239,285],"observed":[149],"human":[151,166],"orthotopic":[152],"breast":[153,246],"ectopic":[155],"colon":[156],"cancer":[157,247],"xenografts":[158,169],"nude":[160],"SCID":[162,276],"mice.":[163],"Established":[164],"PC3":[165],"prostate":[167],"could":[170],"induced":[172],"fully":[175],"regress,":[176],"remaining":[177],"virtually":[178],"nonpalpable":[179],">":[181],"=2":[183],"months":[184],"continuous":[186,235],"therapy,":[187],"after":[188],"tumors":[190,197],"began":[191],"grow":[193],"progressively.":[194],"These":[195],"re-emergent":[196],"not":[199],"resistant":[204],"new":[208],"hosts,":[209],"same":[212],"protocol.":[214],"Regression":[215],"spontaneously":[217],"arising,":[218],"late-stage":[219],"pancreatic":[220],"islet":[221],"cell":[222],"carcinomas":[223],"Rip":[225],"Tag":[226],"transgenic":[227],"also":[230],"observed.":[231],"effects":[233],"enhanced":[240],"significantly":[241],"orthotopic,":[244],"metastatic":[245],"xenograft":[248],"model":[249],"used":[251],"combination":[253],"antivascular":[256],"growth":[258],"factor":[259],"receptor-2":[260],"blocking":[261],"antibody.":[262],"Maximum":[263],"tolerated":[264],"dose":[265],"levels":[266],"established":[267],"other":[269],"strains":[271],"proved":[272,305],"highly":[273],"toxic":[274],"mice,":[277],"whereas":[278],"low-dose":[281],"regimens":[282],"well":[286,321],"tolerated.":[287],"Taken":[288],"together,":[289],"results":[291],"demonstrate":[292],"feasibility":[294],"delivering":[296],"metronomic":[301],"chemotherapy":[302],"regimen,":[303],"safe,":[306],"reasonably":[307],"efficacious,":[308],"potentially":[310],"applicable":[311],"chronic":[313],"treatment.":[314],"regimen":[317],"may":[318],"suited":[322],"integration":[324],"drugs.":[327]},"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":15}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}